Evidence map›Paper›PMID 26159175›Full record

ArticleDiabetes2015

Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human β-Cells.

Hainan Chen, Jeffrey W Kleinberger, Karen K Takane, Fatimah Salim, Nathalie Fiaschi-Taesch, Kyrie Pappas, Ramon Parsons, Jing Jiang, Yue Zhang, Hongtao Liu and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  5. Beta-cell compensation and gestational diabetes.The Journal of biological chemistry · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Hainan ChenDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY hainanchen2011@gmail.com andrew.stewart@mssm.edu.
Jeffrey W KleinbergerUniversity of Maryland School of Medicine, Baltimore, MD.
Karen K TakaneDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Fatimah SalimDuquesne University School of Nursing, Pittsburgh, PA.
Nathalie Fiaschi-TaeschDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Kyrie PappasDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
Ramon ParsonsDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
Jing JiangDivision of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL.
Yue ZhangDivision of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL.
Hongtao LiuDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Peng WangDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Aaron S BenderDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Stuart J FrankDivision of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL Endocrinology Section, Birmingham VA Medical Center, Birmingham, AL.
Andrew F StewartDiabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY hainanchen2011@gmail.com andrew.stewart@mssm.edu.
Icahn School of Medicine at Mount Sinai · USUniversity of Alabama at Birmingham · USBirmingham VA Medical Center · USDuquesne University · USUniversity of Maryland, Baltimore · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human PancreasUC4DK104211 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIM, SEUNG K, POWERS, ALVIN C · 2014 to 2015
$4.0M
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell ReplicationU01DK089538 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEWART, ANDREW F. · 2010 to 2014
$3.6M
Tyrosine Phosphorylation and Growth Hormone SignallingR01DK046395 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FRANK, STUART J · 1997 to 2013
$3.5M
Pancreatic Islet Growth Factors: Transgenic and Viral ModelingR01DK055023 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEWART, ANDREW F. · 1998 to 2015
$3.5M
Growth Hormone Receptor Dimerization/Disulfide LinkageR01DK058259 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FRANK, STUART J · 2001 to 2014
$3.4M
GH Receptor Proteolysis and SheddingI01BX001422 · VA · BIRMINGHAM VA MEDICAL CENTER · PI FRANK, STUART J · 2013 to 2016
–
BLRD VA I01 BX001422NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK046395NIDDK NIH HHS R01 DK055023NIDDK NIH HHS R01 DK058259NIDDK NIH HHS R-01 DK 46395NIDDK NIH HHS R-01 DK55023NIDDK NIH HHS R-01 DK58259NIDDK NIH HHS U-01 DK089538NIDDK NIH HHS U01 DK089538NIDDK NIH HHS UC4 DK104211
6 · The paper itself

Abstract

Pregnancy in rodents is associated with a two- to threefold increase in β-cell mass, which is attributable to large increases in β-cell proliferation, complimented by increases in β-cell size, survival, and function and mediated mainly by the lactogenic hormones prolactin (PRL) and placental lactogens. In humans, however, β-cell mass does not increase as dramatically during pregnancy, and PRL fails to activate proliferation in human islets in vitro. To determine why, we explored the human PRL-prolactin receptor (hPRLR)-Janus kinase 2 (JAK2)-signal transducer and activator of transcription 5 (STAT5)-cyclin-cdk signaling cascade in human β-cells. Surprisingly, adult human β-cells express little or no PRLR. As expected, restoration of the hPRLR in human β-cells rescued JAK2-STAT5 signaling in response to PRL. However, rescuing hPRLR-STAT5 signaling nevertheless failed to confer proliferative ability on adult human β-cells in response to PRL. Surprisingly, mouse (but not human) Stat5a overexpression led to upregulation of cyclins D1-3 and cdk4, as well as their nuclear translocation, all of which are associated with β-cell cycle entry. Collectively, the findings show that human β-cells fail to proliferate in response to PRL for multiple reasons, one of which is a paucity of functional PRL receptors, and that murine Stat5 overexpression is able to bypass these impediments.

Indexed as

AnimalsCell LineCell ProliferationCyclin DCyclin-Dependent Kinase 4HumansInsulin-Secreting CellsMicePhosphorylationProlactinReceptors, ProlactinSignal TransductionSTAT5 Transcription FactorUp-RegulationCyclin DCyclin-Dependent Kinase 4ProlactinReceptors, ProlactinSTAT5 Transcription Factor

Identifiers

PMID26159175
PMCPMC4613973
OpenAlexW1907435047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.